Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study
Abstract
This multi-centre, randomised study included 47 Russian cities, 350 internists, and 1050 patients with uncontrolled treated arterial hypertension (AH). The study aimed at multiple risk factor correction, to reduce total cardiovascular risk level, assessed by the SCORE scale. Antihypertensive therapy was combined with educating education in Health Schools, targeting such risk factors as dyslipidemia, smoking, and overweight or obesity. The control group did not receive any educational intervention. For the first time, the electronic SCORE version was used in a clinical trial as a motivational tool to reduce total cardiovascular risk. The potential effectiveness of this instrument in clinical settings was evaluated.
About the Authors
R. G. Oganov
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
D. V. Nebieridze
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
S. A. Shalnova
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
A. M. Kalinina
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
A. S. Safaryan
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
А. D. Deev
State Research Centre for Preventive Medicine, Federal Agency on High Medical Technologies
Russian Federation
Russian Federation
Moscow
References
1. Оганов Р.Г. Профилактика сердечно-сосудистых заболеваний: возможности практического здравоохранения. Кардиоваск тер профил 2002; 1: 5-9.
2. Рекомендации по диагностике и лечению артериальной гипертензии. Второй пересмотр. Кардиоваск тер профил 2008; 3(3) ч.1: 105-20.
3. Шальнова С.А., Баланова Ю.А., Константинов В.В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. РКЖ 2006; 4: 45-50.
4. Небиеридзе Д.В., Жуковский Г.С., Бритов А.Н. Мягкая артериальная ипертония: гетерогенность и необходимость дифференцированной профилактики. Кардиология 1996; 3: 63-7.
5. Леонова М.В., Белоусов Ю.Б.Белоусов Д.Ю. и др. Результаты фармакоэпидемиологического исследования больных артериальной гипертонией в России. Качеств клин практ 2004; 1: 17-27.
6. Шапиро И.А., Калинина А.М. Профилактическая медицинская помощь больным артериальной гипертонией в амбулаторно-поликлинических учреждениях Хабаровского края: состояние и перспективы. Кардиоваск тер профил 2002; 1: 16-22.
7. The АDVANCE Collaborative Group: Rationale and design of the АDVANCE Study: a randomised trial of blood pressure lowering and intensive glucose control in high risk individuals with Type 2 diabetes mellitus. J Hypertens 2001; 19: 21-8.
Review
For citations:
Oganov R.G., Nebieridze D.V., Shalnova S.A., Kalinina A.M., Safaryan A.S., Deev А.D. Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study. Cardiovascular Therapy and Prevention. 2009;8(6):50-53. (In Russ.)
Views:
358
Email this article 
